Sinopharm Group Co. Ltd.

Sinopharm Group Co. Ltd.

SHTDY

$9.39

Updated: 23/09/2026, 17:06:01

Market Cap
$5.86B
Sector
Healthcare
Industry
Medical - Distribution
Country
CN
Stock valuation chart
One-year closing share-price history for SHTDY
Company Profile

Sinopharm Group Co. Ltd. is a prominent Chinese enterprise specializing in the wholesale and retail of pharmaceuticals, medical devices, and other healthcare products. The company's diverse operations are structured into four key segments. The Pharmaceutical Distribution segment is responsible for supplying a wide array of pharmaceutical products to various healthcare entities, including hospitals, clinics, and retail pharmacies. This segment also provides comprehensive logistics and value-added services to both domestic and international manufacturers and suppliers of pharmaceutical and healthcare items. The Medical Devices segment focuses specifically on the distribution of medical equipment. Through its Retail Pharmacy segment, the company operates and franchises an extensive chain of drugstores, which totaled 10,259 locations as of December 31, 2021. The Other Business segment encompasses the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core activities, Sinopharm Group also engages in property rental and management, distributes specialized products such as Chinese herbal medicines, antibiotics, and biological products, and offers a suite of services. These include IT development, medicine, business, health, and market information consulting, international trade (import/export of goods and technology), market investigation, and convention and exhibition services. Furthermore, the company is involved in medical project investment, consulting, and technology training. To enhance its commercial capabilities and transformation, Sinopharm Group Co. Ltd. maintains a strategic partnership with I-Mab. Founded in 2003, the company is headquartered in Shanghai, China, and operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

USD
OTC
CEO: Wanyong Lian
Employees: 94,910
https://www.sinopharmgroup.com.cn
Asset Summaries
Latest generated summaries for SHTDY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SHTDY.
Share price
$9.39
Market cap
$5.86B
Exchange
OTC
Currency
USD
CEO
Wanyong Lian
Employees
94,910
IPO date
25/08/2016
Beta
0.449
Last dividend
$0.00
Day range
$9.34 – $9.43
52-week range
$9.20 – $14.87
1-day performance
-1.29%
1-year performance
2.03%
Current drawdown (1Y)
-36.87%
CIK
N/A
CUSIP
82937K101
ISIN
US82937K1016
Created
07/12/2025, 14:13:25
Last update
23/09/2026, 17:06:01

Track Sinopharm Group Co. Ltd. with an AI analyst

See which prediction-market events move SHTDY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to SHTDY from your Railway `news_articles` table.

No news found for this symbol.